Anagenics Ltd has released a press release.
ASX Market Release - Reinstatement
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Anagenics
- Cellmid records highest ever quarterly sales for evolis
- Midkine Antibodies Show Anti-Tumor Activity In Brain Cancer
- European Midkine Patent For Surgical Adhesion Allowed
- New Publication for Cellmids Midkine Antibody
- Transcript of Cellmid Investor Briefing Call
Later from Anagenics
- Cellmid: Appendix 3Y- Change of Director’s Interest Notice
- USA launch of evolis
- Cellmid receives 831K R&D tax credit
- Cellmid Updates on CxBladder License
- Cellmid receives australian govt grant for midkine programme
Follow Anagenics into a list and get an email when it puts out news.
Follow Anagenics